Sanofi has created two new commercial organisation to better align with its business priorities and appointed two new members to the executive committee. Two new units will be created, Global Commercial Operations and Global Divisions & Strategic Commercial Development to replace the former Global Operations. Peter Guenter, currently senior vice president, Europe, will be appointed executive vice president, Global Commercial Operations. Pascale Witz, currently president and CEO of medical diagnostics at Ge Healthcare, will join Sanofi and be appointed executive vice president, global Divisions & Strategic Commercial Development. Both will join the Executive Committee.

Christopher A Viehbacher, CEO, said, “The appointment of these two new leaders will enable us to strengthen our growth platforms and ensure the success of our new products to deliver a sustainable future for our company. Peter is a proven leader with a strong track record in achieving ambitious commercial objectives. Pascale's diversified experience in healthcare and acute commercial focus will be a great addition to Sanofi.”

Peter Guenter will focus on in-market execution across the diverse regions of North America, Latin America, Europe, Asia, Japan and Pacific and Intercontinental. Pascale Witz will be responsible for setting the strategic direction and guiding product development of the Group key business. She will have direct responsibilities for the diabetes, oncology and Pharmaceutical customer solution divisions, as well as a new structure for consumer healthcare.